The WAYFINDER Study: A Research Study recruiting patients with severe asthma that is hard to control.
Asthma is a condition in which your airways narrow and swell. This can make it hard to breathe. It causes symptoms such as coughing, wheezing (a whistling sound when you breathe), shortness of breath, and chest tightness.
The World Health Organization estimates that asthma affects 262 million people worldwide. There is no cure for asthma, but medications can help control symptoms.
The WAYFINDER Study is testing an approved medication called Tezspire (tezepelumab). It has been designed to stop a certain molecule involved in lung inflammation. The medication is considered investigational in this research study. This study will answer some important medical questions, such as:
- Does the study drug help control asthma when oral corticosteroids (OCS) are reduced?
- Can you stop OCS therapy if you get the study drug once every 4 weeks?
If you have severe asthma, this study may be an option for you.
Is the WAYFINDER study an option for you?
You may qualify to participate if you:
- Are 18 to 80 years of age
- Have used an inhaled corticosteroid medication plus a long-acting BETA agonist to help control your asthma for the last 6 months
- Have taken a long-term oral corticosteroid (OCS) therapy for your asthma for the last 3 months
- Have had at least one asthma exacerbation in the last 12 months
Ask your doctor about these eligibility criteria and if you may qualify.
Before choosing to participate in a clinical research study, you should always speak to your doctor to find out more information about clinical research.